(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.96%6.05B | 10.12%10.53B | 14.90%5.99B | 11.22%9.56B | 14.15%5.21B | 35.34%8.6B | 40.26%4.57B | -3.61%6.35B | -9.24%3.26B | 10.61%6.59B |
Operating income | 0.96%6.05B | 10.12%10.53B | 14.90%5.99B | 11.22%9.56B | 14.15%5.21B | 35.34%8.6B | 40.26%4.57B | -3.61%6.35B | -9.24%3.26B | 10.61%6.59B |
Cost of sales | -15.79%-2.46B | -10.93%-4.01B | -8.63%-2.12B | -7.76%-3.61B | -16.66%-1.95B | -44.57%-3.35B | -37.73%-1.67B | 9.08%-2.32B | 7.56%-1.22B | 8.85%-2.55B |
Operating expenses | -15.79%-2.46B | -10.93%-4.01B | -8.63%-2.12B | -7.76%-3.61B | -16.66%-1.95B | -44.57%-3.35B | -37.73%-1.67B | 9.08%-2.32B | 7.56%-1.22B | 8.85%-2.55B |
Gross profit | -7.16%3.59B | 9.62%6.52B | 18.66%3.87B | 13.42%5.95B | 12.70%3.26B | 30.04%5.25B | 41.77%2.89B | -0.15%4.04B | -10.20%2.04B | 27.83%4.04B |
Selling expenses | 1.57%-1.61B | -11.32%-2.57B | -19.27%-1.64B | 3.81%-2.31B | 2.94%-1.37B | -28.91%-2.4B | -48.06%-1.41B | 16.94%-1.86B | 24.14%-955.52M | -27.25%-2.24B |
Administrative expenses | 12.89%-606.2M | -13.24%-1.23B | -26.35%-695.89M | -19.83%-1.09B | -28.34%-550.76M | -32.74%-909.62M | -39.62%-429.15M | -12.40%-685.24M | 6.81%-307.37M | -10.34%-609.62M |
Revaluation surplus | 93.22%443.75M | 314.11%117.55M | 158.50%229.66M | -111.52%-54.9M | -231.34%-392.56M | 75.56%476.5M | 5,081.53%298.89M | 2,668.46%271.41M | ---6M | ---10.57M |
-Changes in the fair value of derivative financial instruments | ---- | -178.98%-31.37M | ---- | 575.69%39.72M | ---- | ---8.35M | ---- | ---- | ---- | ---- |
-Changes in the fair value of financial assets | 93.22%443.75M | 257.38%148.92M | 158.50%229.66M | -119.52%-94.62M | -231.34%-392.56M | 78.64%484.85M | 5,081.53%298.89M | 2,668.46%271.41M | ---6M | ---10.57M |
Impairment and provision | ---- | -1,072.83%-157.45M | ---59.65M | -3,703.12%-13.43M | ---- | 98.02%-353K | ---- | 69.21%-17.81M | ---- | -3,197.21%-57.83M |
-Goodwill impairment | ---- | -7.39%-39.14M | ---- | ---36.44M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | -614.04%-118.32M | ---59.65M | 6,620.40%23.02M | ---- | 98.02%-353K | ---- | 69.21%-17.81M | ---- | -3,197.21%-57.83M |
Special items of operating profit | 131.75%82.28M | -150.96%-107.81M | -409.81%-259.14M | -39.38%211.57M | 36.67%83.64M | -9.00%349.02M | -35.97%61.2M | 45.47%383.55M | 38.58%95.58M | 57.87%263.66M |
Operating profit | 31.36%1.9B | -4.59%2.57B | 40.73%1.45B | -2.41%2.7B | -27.09%1.03B | 29.99%2.76B | 62.46%1.41B | 53.30%2.13B | 15.34%867.28M | 36.30%1.39B |
Financing cost | 23.94%-86.12M | -49.20%-205.15M | -79.13%-113.23M | -47.90%-137.49M | -167.05%-63.21M | 19.46%-92.96M | 59.27%-23.67M | 21.22%-115.42M | 31.55%-58.12M | 27.94%-146.5M |
Share of profits of associates | 376.26%18.82M | 42.89%-25.01M | 85.92%-6.81M | -138.46%-43.79M | -308.46%-48.38M | 83.71%113.86M | -62.66%23.21M | -46.09%61.98M | 399.95%62.16M | 66.18%114.96M |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K |
Earning before tax | 38.18%1.83B | -6.86%2.34B | 44.77%1.33B | -9.65%2.52B | -34.99%915.7M | 34.35%2.79B | 61.66%1.41B | 52.92%2.07B | 28.23%871.32M | 53.41%1.36B |
Tax | 9.20%-244.18M | -7.19%-448.76M | -23.49%-268.93M | -9.94%-418.64M | -6.60%-217.78M | -30.24%-380.8M | -23.44%-204.3M | -26.85%-292.37M | -33.54%-165.51M | -56.30%-230.49M |
After-tax profit from continuing operations | 50.24%1.59B | -9.67%1.9B | 51.42%1.06B | -12.76%2.1B | -42.04%697.92M | 35.02%2.41B | 70.62%1.2B | 58.26%1.78B | 27.05%705.82M | 52.83%1.13B |
Earning after tax | 50.24%1.59B | -9.67%1.9B | 51.42%1.06B | -12.76%2.1B | -42.04%697.92M | 35.02%2.41B | 70.62%1.2B | 58.26%1.78B | 27.05%705.82M | 52.83%1.13B |
Minority profit | 8.55%29.76M | -17.99%15.44M | 319.55%27.42M | 662.74%18.83M | -837.19%-12.49M | 121.56%2.47M | 113.35%1.69M | 55.02%-11.45M | -247.64%-12.69M | -207.10%-25.46M |
Profit attributable to shareholders | 51.35%1.56B | -9.59%1.88B | 44.90%1.03B | -13.45%2.08B | -40.92%710.41M | 34.02%2.4B | 67.37%1.2B | 55.76%1.79B | 31.36%718.51M | 61.50%1.15B |
Basic earnings per share | 52.51%0.4441 | -8.69%0.536 | 44.44%0.2912 | -13.32%0.587 | -40.50%0.2016 | 30.16%0.6772 | 59.29%0.3388 | 48.15%0.5203 | 23.52%0.2127 | 26.60%0.3512 |
Diluted earnings per share | 52.51%0.4441 | -8.69%0.536 | 44.44%0.2912 | -13.32%0.587 | -40.50%0.2016 | 30.16%0.6772 | 59.29%0.3388 | 51.16%0.5203 | 28.60%0.2127 | 29.89%0.3442 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data